SEVERE NEUROTOXICITY FOLLOWING HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND THIOTEPA IN THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA: THE UK EXPERIENCE

被引:0
|
作者
Hayden, J. [1 ]
Vivekanandan, S. [2 ]
Thorp, N. [3 ]
Mayles, H. [4 ]
Baker, A. [4 ]
Pizer, B. [1 ]
Horan, G. [5 ]
机构
[1] Alder Hey Childrens NHS Fdn Trust, Paediat Oncol, Liverpool, Merseyside, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Paediat Oncol, Cambridge, England
[3] Clatterbridge Canc Ctr NHS Fdn Trust, Oncol, Wirral, Merseyside, England
[4] Clatterbridge Canc Ctr NHS Fdn Trust, Clin Radiotherapy, Wirral, Merseyside, England
[5] Cambridge Univ Hosp NHS Fdn Trust, Clin Oncol, Cambridge, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O-105
引用
收藏
页码:S172 / S173
页数:2
相关论文
共 50 条
  • [31] Results of tandem high-dose chemotherapy and autologous stem cell transplantation using thiotepa in children with high-risk medulloblastoma
    Daylidite, V.
    Daylidite, Vidmante V.
    Subbotina, Natalia N.
    Dolgopolov, Igor S.
    Babelyan, Stepan S.
    Levashow, Andrey S.
    Mentkevich, Georgy L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S513 - S513
  • [32] Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour
    Szychot, Elwira
    Seunarine, Kiran
    Mankad, Kshitij
    Thust, Steffi
    Clark, Chris
    Gaze, Mark N.
    Michalski, Antony
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [33] IMPACT OF INDUCTION CHEMOTHERAPY, HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND HIGH DOSE THIOTEPA ON BRAIN VOLUME LOSS AND FUNCTIONAL STATUS OF CHILDREN WITH PRIMITIVE NEUROECTODERMAL TUMOUR (PNET)
    Szychot, E.
    Mankad, K.
    Thust, S.
    Seunarine, K.
    Clark, C.
    Michalski, A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S216 - S216
  • [34] Adjuvant radiotherapy for high-risk patients following radical prostatectorny
    Swanson, Gregory P.
    Thompson, Ian M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (06) : 515 - 519
  • [35] Continuous hyperfractionated accelerated radiotherapy (CHART) in non small cell lung cancer: A single centre experience as standard treatment
    Hatton, M
    Omar, D
    Fisher, P
    Peter, P
    Mohanamurali, K
    LUNG CANCER, 2005, 49 : S307 - S307
  • [36] Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART)
    Jenkins, P
    D'Amico, K
    Benstead, K
    Elyan, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02): : 360 - 366
  • [37] A PROSPECTIVE TRIAL OF ACCELERATED RADIOTHERAPY IN THE POSTOPERATIVE TREATMENT OF HIGH-RISK SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    TROTTI, A
    KLOTCH, D
    ENDICOTT, J
    RIDLEY, M
    GREENBERG, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (01): : 13 - 21
  • [38] Multicenter Experience With Intravascular Lithotripsy for Treatment of Severe Calcification During TCAR for High-risk Patients
    DiLosa, Kathryn L.
    Schonefeld, Sally
    El-Khoury, Rym
    Eichler, Charles
    DiBartolomeo, Alexander D.
    Magee, Gregory A.
    Yi, Jeniann
    Simioni, Andrea
    Mouawad, Nicolas
    Maximus, Steven
    Baril, Donald
    Aranson, Nathan
    Azizzad, Ali
    Humphries, Misty D.
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (06) : E54 - E55
  • [39] Transition to psychosis in a high-risk sample:: The experience of ED:IT, Birmingham, UK
    Skeate, A
    Patterson, P
    Birchwood, M
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 44 - 44
  • [40] Preclinical Modeling of Clinically Relevant Radiation Therapy for Treatment of High-Risk Medulloblastoma
    Smith, S. M. C.
    Tinkle, C. L.
    Bianski, B. M.
    Orr, B. A.
    Robinson, G. W.
    Morel, V.
    Gilbertson, R. J.
    Gajjar, A.
    Merchant, T. E.
    Roussel, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S147 - S147